RightFit
RecruitingNot applicable

Safer Aging With Diabetes Monitoring

Pragmatic Clinical Trial of Continuous Glucose Monitoring-based Interventions for Safe Insulin Use in High-Risk Older Adults With Type 2 Diabetes

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
75 Years and older
Sex
All sexes
Healthy volunteers
Not accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

Not stated in the study description — ask the study team about visits and procedures.

Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study tests a program that teaches safer insulin use with continuous glucose monitoring, which tracks blood sugar throughout the day. It is for adults age 75 or older with type 2 diabetes who use insulin and have a higher risk of very low blood sugar.

Older adults with type 2 diabetes are at higher risk for severe hypoglycemia and its related complications (including hospitalization and death) when taking insulin. This study proposes to evaluate, in a randomized clinical trial, a strategy of safe insulin prescribing based on an educational program that leverages continuous glucose monitoring to support older adults at high risk for hypoglycemia. If the aims of this project are achieved, this novel care strategy could be widely applied to reduce severe hypoglycemia episodes in older, high-risk adults with type 2 diabetes.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • Age 75 or older.
  • Have type 2 diabetes.
  • Currently take insulin.
  • Have a higher risk of low blood sugar, with low blood sugar in the past year reported by you or shown in health care use.
  • Can communicate in English.
  • Can access email and the Internet.

Who can't join

  • Get dialysis, a treatment that filters blood when the kidneys do not work well.
  • Have dementia, a condition that affects memory and thinking.
  • Have a pacemaker or an implanted defibrillator, devices that help control heartbeats.
  • Use an insulin pump.
  • Have a severe mental illness.
  • Have severe vision problems.
  • Are in hospice care.
  • Use or recently used a continuous glucose monitor, a device that tracks blood sugar.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

Inclusion Criteria: * Age 75 years and older * Diagnosis of Type 2 Diabetes * Current treatment with insulin * Increased hypoglycemia risk (prior year hypoglycemia by self-report or utilization) * Able to communicate in English * Able to access email and the Internet Exclusion Criteria: * On renal dialysis * Dementia * Pacemaker or Automatic Implantable Cardioverter Defibrillator * Using insulin pump * Severe Mental Illness * Severe Visual Impairment * In Hospice * Current or recent CGM use

Study sites (6)

CA